Report triggers quibbles over QALYs, a staple of health metrics
Nat Med
.
2013 Mar;19(3):248.
doi: 10.1038/nm0313-248.
Author
David Holmes
PMID:
23467219
DOI:
10.1038/nm0313-248
No abstract available
Publication types
News
MeSH terms
Cost-Benefit Analysis
Drug Approval*
Humans
Quality-Adjusted Life Years*
State Medicine
United Kingdom